Agios Pharmaceuticals Current Ratio 2012-2019 | AGIO
Agios Pharmaceuticals current ratio from 2012 to 2019. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| Agios Pharmaceuticals Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2019-03-31 | $0.56B | $0.08B | 6.89 |
| 2018-12-31 | $0.61B | $0.09B | 6.56 |
| 2018-09-30 | $0.70B | $0.09B | 8.21 |
| 2018-06-30 | $0.75B | $0.09B | 8.88 |
| 2018-03-31 | $0.80B | $0.08B | 10.75 |
| 2017-12-31 | $0.45B | $0.10B | 4.69 |
| 2017-09-30 | $0.53B | $0.09B | 6.00 |
| 2017-06-30 | $0.61B | $0.09B | 6.46 |
| 2017-03-31 | $0.51B | $0.08B | 6.15 |
| 2016-12-31 | $0.56B | $0.09B | 6.33 |
| 2016-09-30 | $0.60B | $0.08B | 7.70 |
| 2016-06-30 | $0.48B | $0.07B | 7.20 |
| 2016-03-31 | $0.33B | $0.05B | 7.31 |
| 2015-12-31 | $0.34B | $0.05B | 6.38 |
| 2015-09-30 | $0.37B | $0.05B | 7.47 |
| 2015-06-30 | $0.39B | $0.05B | 8.63 |
| 2015-03-31 | $0.36B | $0.04B | 10.01 |
| 2014-12-31 | $0.36B | $0.06B | 5.89 |
| 2014-09-30 | $0.25B | $0.04B | 7.06 |
| 2014-06-30 | $0.25B | $0.05B | 5.49 |
| 2014-03-31 | $0.17B | $0.03B | 5.06 |
| 2013-12-31 | $0.17B | $0.04B | 4.60 |
| 2013-09-30 | $0.20B | $0.04B | 5.32 |
| 2013-06-30 | $0.10B | $0.04B | 2.77 |
| 2013-03-31 | $0.00B | $0.00B | 0.00 |
| 2012-12-31 | $0.00B | $0.00B | 0.00 |
| 2012-09-30 | $0.00B | $0.00B | 0.00 |
| 2012-06-30 | $0.00B | $0.00B | 0.00 |
| 2011-12-31 | $0.00B | $0.00B | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $2.854B | $0.094B |
| Agios Pharmaceuticals, Inc. is a biopharmaceutical company. It discovers and develops therapeutics in the field of cancer metabolism and inborn errors of metabolism. The Company's products include AG-221, AG-120, enzyme glutaminase and AG-348. Agios Pharmaceuticals, Inc. is based in Cambridge, Massachusetts. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $133.672B | 25.95 |
| Medtronic (MDT) | Ireland | $117.445B | 17.17 |
| Stryker (SYK) | United States | $68.767B | 24.54 |
| Boston Scientific (BSX) | United States | $51.857B | 24.86 |
| Baxter (BAX) | United States | $38.426B | 24.22 |
| Zimmer Biomet Holdings (ZBH) | United States | $23.740B | 15.25 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $18.286B | 0.00 |
| ResMed (RMD) | United States | $16.069B | 30.70 |
| Canopy Growth (CGC) | Canada | $14.891B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.726B | 46.26 |
| Aurora Cannabis (ACB) | Canada | $8.610B | 84.90 |
| Perrigo (PRGO) | Ireland | $6.742B | 11.40 |
| Hill-Rom Holdings (HRC) | United States | $6.410B | 19.43 |
| Insulet (PODD) | United States | $6.211B | 452.52 |
| GW Pharmaceuticals (GWPH) | United Kingdom | $5.395B | 0.00 |
| Haemonetics (HAE) | United States | $5.107B | 41.90 |
| ICU Medical (ICUI) | United States | $4.607B | 27.49 |
| Hutchison China MediTech (HCM) | China | $3.581B | 0.00 |
| NuVasive (NUVA) | United States | $3.197B | 26.11 |
| Neogen (NEOG) | United States | $3.035B | 49.35 |
| Quidel (QDEL) | United States | $2.215B | 22.99 |
| National Vision Holdings (EYE) | United States | $2.083B | 44.38 |
| Aphria (APHA) | $1.662B | 0.00 | |
| HEXO (HEXO) | $1.463B | 0.00 | |
| Cardiovascular Systems (CSII) | United States | $1.368B | 785.40 |
| Phibro Animal Health (PAHC) | United States | $1.179B | 17.66 |
| AtriCure (ATRC) | United States | $1.136B | 0.00 |
| VAREX IMAGING (VREX) | United States | $1.097B | 23.29 |
| NanoString Technologies (NSTG) | United States | $0.939B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $0.929B | 24.68 |
| Omeros (OMER) | United States | $0.913B | 0.00 |
| MacroGenics (MGNX) | United States | $0.890B | 0.00 |
| PetIQ (PETQ) | United States | $0.812B | 19.73 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.751B | 21.07 |
| Cerus (CERS) | United States | $0.743B | 0.00 |
| TG Therapeutics (TGTX) | United States | $0.594B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $0.534B | 25.84 |
| OraSure Technologies (OSUR) | United States | $0.524B | 24.11 |
| Surmodics (SRDX) | United States | $0.516B | 74.96 |
| Quanterix (QTRX) | United States | $0.500B | 0.00 |
| Meridian Bioscience (VIVO) | United States | $0.478B | 14.62 |
| Evolus (EOLS) | United States | $0.475B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.351B | 109.94 |
| Neptune Technologies & Bioresources Inc (NEPT) | Canada | $0.314B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.303B | 21.00 |
| Vapotherm (VAPO) | United States | $0.289B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.282B | 0.00 |
| Zynex (ZYXI) | United States | $0.242B | 25.07 |
| Owens & Minor (OMI) | United States | $0.225B | 4.76 |
| Cytosorbents (CTSO) | United States | $0.223B | 0.00 |
| Bovie Medical (APYX) | United States | $0.206B | 0.00 |
| Chimerix (CMRX) | United States | $0.174B | 0.00 |
| Fonar (FONR) | United States | $0.135B | 7.08 |
| Chembio Diagnostics (CEMI) | United States | $0.132B | 0.00 |
| Surface Oncology (SURF) | United States | $0.110B | 0.00 |
| Female Health (VERU) | United States | $0.104B | 0.00 |
| InfuSystems Holdings (INFU) | United States | $0.098B | 0.00 |
| United-Guardian (UG) | United States | $0.092B | 20.31 |
| Neurotrope (NTRP) | United States | $0.092B | 0.00 |
| Insys Therapeutics (INSY) | United States | $0.071B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.063B | 21.67 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.053B | 0.00 |
| ImmuCell (ICCC) | United States | $0.044B | 0.00 |
| Senestech (SNES) | United States | $0.040B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.033B | 0.00 |
| Conatus Pharmaceuticals (CNAT) | United States | $0.028B | 0.00 |
| BRAINSWAY LTD (BWAY) | Israel | $0.026B | 0.00 |
| Valeritas Holdings (VLRX) | United States | $0.022B | 0.00 |
| Myomo (MYO) | United States | $0.017B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.011B | 0.00 |
| InVivo Therapeutics Holdings (NVIV) | United States | $0.010B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Akers Biosciences Inc (AKER) | United States | $0.009B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.006B | 4.54 |
